Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Cancer, Peritoneal Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02739698
What this trial is testing

Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia

Who this might be right for
Peritoneal Carcinomatosis
Maimónides Biomedical Research Institute of Córdoba 32
Early research (Phase 1)Study completedNCT02903771
What this trial is testing

Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.

Who this might be right for
Ovarian NeoplasmsFallopian Tube NeoplasmsPeritoneal Neoplasms
Kazia Therapeutics Limited 32
Testing effectiveness (Phase 2)Study completedNCT00035100
What this trial is testing

EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer

Who this might be right for
Ovarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms
Novartis Pharmaceuticals 54
Not applicableStudy completedNCT04512209
What this trial is testing

Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncology

Who this might be right for
Carcinomatosis, PeritonealPancreas CancerOvarian Cancer+1 more
University Hospital, Ghent 22
Testing effectiveness (Phase 2)Ended earlyNCT03287271
What this trial is testing

ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK

Who this might be right for
Ovarian Cancer
Michael McHale 8
Early research (Phase 1)Study completedNCT00045175
What this trial is testing

UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
University Health Network, Toronto 33
Testing effectiveness (Phase 2)UnknownNCT02033616
What this trial is testing

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas

Who this might be right for
Stage III Ovarian CarcinomaStage IV Ovarian CarcinomaFallopian Tube Carcinoma+1 more
Aivita Biomedical, Inc. 99
Early research (Phase 1)Study completedNCT01281514
What this trial is testing

Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer

Who this might be right for
Fallopian Tube CancerPeritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
Fox Chase Cancer Center 21
Early research (Phase 1)Looking for participantsNCT03968406
What this trial is testing

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Who this might be right for
Malignant Female Reproductive System NeoplasmRecurrent Cervical CarcinomaRecurrent Endometrial Carcinoma+22 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07044349
What this trial is testing

Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Beijing Biostar Pharmaceuticals Co., Ltd. 72
Not applicableStudy completedNCT02578888
What this trial is testing

Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies

Who this might be right for
Cervical CarcinomaOvarian CarcinomaPrimary Peritoneal Carcinoma+7 more
Albert Einstein College of Medicine 95
Testing effectiveness (Phase 2)Study completedNCT01001910
What this trial is testing

Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Albert Einstein College of Medicine 22
Large-scale testing (Phase 3)Study completedNCT00003120
What this trial is testing

S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
SWOG Cancer Research Network 308
Testing effectiveness (Phase 2)WithdrawnNCT00369954
What this trial is testing

Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00083122
What this trial is testing

Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Who this might be right for
Recurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity CancerStage IIIA Ovarian Epithelial Cancer+7 more
National Cancer Institute (NCI) 45
Not applicableUnknownNCT01823731
What this trial is testing

A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis Index

Who this might be right for
Ovarian Cancer
National Cancer Center, Korea 50
Large-scale testing (Phase 3)UnknownNCT01654146
What this trial is testing

ICON8: Weekly Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Medical Research Council 1,485
Testing effectiveness (Phase 2)Study completedNCT00030446
What this trial is testing

Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
NCIC Clinical Trials Group 50
Not applicableStudy completedNCT01471483
What this trial is testing

Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00093496
What this trial is testing

Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer

Who this might be right for
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial CancerStage III Ovarian Epithelial Cancer+1 more
National Cancer Institute (NCI) 29
Next Page